000 01466 a2200433 4500
005 20250513174637.0
264 0 _c19990517
008 199905s 0 0 eng d
022 _a1079-5642
024 7 _a10.1161/01.atv.19.4.1060
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMooser, V
245 0 0 _aEffect of cardiopulmonary bypass and heparin on plasma levels of Lp(a) and Apo(a) fragments.
_h[electronic resource]
260 _bArteriosclerosis, thrombosis, and vascular biology
_cApr 1999
300 _a1060-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAged
650 0 4 _aApolipoproteins A
_xblood
650 0 4 _aCardiopulmonary Bypass
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHeparin
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aLipoprotein(a)
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aTinguely, F
700 1 _aFontana, P
700 1 _aLenain, V
700 1 _aVaglio, M
700 1 _aRuchat, P
700 1 _avon Segesser, L K
700 1 _aMarcovina, S M
700 1 _aMarkert, M
700 1 _aDarioli, R
700 1 _aNicod, P
773 0 _tArteriosclerosis, thrombosis, and vascular biology
_gvol. 19
_gno. 4
_gp. 1060-5
856 4 0 _uhttps://doi.org/10.1161/01.atv.19.4.1060
_zAvailable from publisher's website
999 _c10155337
_d10155337